Osaic Holdings
CGTX icon

Osaic Holdings’s Cognition Therapeutics CGTX Stock Holding History

Osaic Holdings’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.43K Sell
3,200
-1,400
-30% -$1.63K ﹤0.01% 6983
2025
Q4 		$6.21K Sell
4,600
-8,000
-63% -$13K ﹤0.01% 6575
2025
Q3 		$18K Buy
+12,600
New +$17.2K ﹤0.01% 6000
2025
Q2 		– Sell
-7,200
Closed -$3.02K – 7759
2025
Q1 		$3.02K Sell
7,200
-11,800
-62% -$6.93K ﹤0.01% 6432
2024
Q4 		$13.3K Buy
19,000
+17,200
+956% +$8.5K ﹤0.01% 5610
2024
Q3 		$846 Buy
+1,800
New +$1.86K ﹤0.01% 6885
2024
Q2 		– Sell
-1,165
Closed -$2.12K – 7433
2024
Q1 		$2.12K Buy
+1,165
New +$2.4K ﹤0.01% 6447

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Osaic Holdings's CGTX Position: Q1 2026 in Review

Osaic Holdings reduced its Cognition Therapeutics (CGTX) stake by 30% in Q1 2026, selling an estimated $1.63K and leaving 3,200 shares worth $2.43K. The position accounts for ﹤0.01% of the portfolio, ranked #6983.

Osaic Holdings first reported a position in CGTX in Q1 2024 and has held it in 7 quarters since. The position peaked at $18K in Q3 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Osaic Holdings held 3,200 shares of Cognition Therapeutics worth $2.43K as of Q1 2026.
  • Osaic Holdings sold 1,400 Cognition Therapeutics shares in Q1 2026, an estimated $1.63K.
  • Cognition Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6983 holding.
  • Osaic Holdings first reported a position in Cognition Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • Osaic Holdings's Cognition Therapeutics position peaked at $18K in Q3 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.